Package 57894-510-01
Brand: rybrevant faspro
Generic: amivantamab and hyaluronidase-lpuj (human recombinant)Package Facts
Identity
Package NDC
57894-510-01
Digits Only
5789451001
Product NDC
57894-510
Description
1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE
Marketing
Marketing Status
Brand
rybrevant faspro
Generic
amivantamab and hyaluronidase-lpuj (human recombinant)
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "e037897a-b42a-413f-8f3f-c0f5ee7b5125", "openfda": {"nui": ["N0000175531", "M0009499"], "upc": ["0357894522010"], "unii": ["0JSR7Z0NB6", "743QUY4VD8"], "rxcui": ["2729297", "2729304", "2729306", "2729307", "2735796", "2735797", "2735803", "2735804"], "spl_set_id": ["9e58b045-e352-4f62-99bf-77fae1bebc69"], "pharm_class_cs": ["Glycoside Hydrolases [CS]"], "pharm_class_epc": ["Endoglycosidase [EPC]"], "manufacturer_name": ["Janssen Biotech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (57894-510-01) / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "57894-510-01", "marketing_start_date": "20251219"}], "brand_name": "Rybrevant Faspro", "product_id": "57894-510_e037897a-b42a-413f-8f3f-c0f5ee7b5125", "dosage_form": "INJECTION", "pharm_class": ["Endoglycosidase [EPC]", "Glycoside Hydrolases [CS]"], "product_ndc": "57894-510", "generic_name": "AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)", "labeler_name": "Janssen Biotech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rybrevant Faspro", "active_ingredients": [{"name": "AMIVANTAMAB", "strength": "1600 mg/10mL"}, {"name": "HYALURONIDASE (HUMAN RECOMBINANT)", "strength": "20000 mg/10mL"}], "application_number": "BLA761433", "marketing_category": "BLA", "marketing_start_date": "20251219", "listing_expiration_date": "20271231"}